Species: Alloprevotella sp. HMT-473 (HMT-0473) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0473: [Body Sites Data]
[Taxon Description]
| Life Page: Alloprevotella sp. HMT-473
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.11 | 0.11 | 0.02 | 0.88 | 0.09 | 0.02 | 0.22 | 0.08 | 0.18 | 0.04 | 0 | 0 | 0 | 0.01 | 0 | 0.02 | 0 | 0.01 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.04 | 0.03 | 0.02 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.33 | 0.35 | 0.04 | 1.85 | 0.20 | 0.02 | 0.54 | 0.12 | 0.16 | 0.08 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 |
| Stdev | 0.20 | 0.28 | 0.02 | 1.01 | 0.26 | 0 | 0.24 | 0.04 | 0.48 | 0.07 | 0.01 | 0 | 0 | 0 | 0 | 0.04 | 0.01 | 0.01 |
| Prev(%) | 29.17 | 30.13 | 4.17 | 60.00 | 7.43 | 0 | 25.00 | 0 | 9.09 | 9.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.03 | 0.03 | 3.70 | 0.35 | 0.17 | 0.22 | 0.19 | 0.17 | 0.11 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.04 | 12.58 | 0.41 | 0.46 | 0.64 | 0.54 | 0.40 | 0.36 | 0 |
| Stdev | 0.10 | 0.17 | 6.40 | 1.24 | 0.35 | 0.41 | 0.39 | 0.39 | 0.26 | 0.01 |
| Prev(%) | 24.68 | 15.58 | 59.74 | 48.05 | 51.95 | 54.55 | 54.55 | 55.84 | 41.56 | 2.60 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.43 | 0.34 | 7.78 | 0.71 | 0.40 | 1.04 | 0.60 | 0.84 | 0.25 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.35 | 1.13 | 24.54 | 1.26 | 1.35 | 2.88 | 1.67 | 2.15 | 0.68 | 0 |
| Stdev | 0.88 | 0.67 | 11.08 | 2.75 | 0.70 | 1.80 | 1.25 | 2.47 | 0.63 | 0 |
| Prev(%) | 58.11 | 59.46 | 73.65 | 73.65 | 67.57 | 79.73 | 64.86 | 70.95 | 53.38 | 2.10 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.31 | 0.20 | 5.44 | 0.43 | 0.35 | 0.72 | 0.47 | 0.64 | 0.22 | 0.08 | 0.02 | 0.02 | 0.07 | 0.14 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.51 | 0.62 | 21.19 | 0.82 | 0.97 | 1.79 | 1.19 | 1.40 | 0.56 | 0.10 | 0.03 | 0.02 | 0.16 | 0.32 | 0 | 0 | 0 | 0 |
| Stdev | 0.99 | 0.58 | 8.59 | 1.44 | 0.70 | 1.43 | 1.14 | 2.03 | 0.83 | 0.50 | 0.13 | 0.08 | 0.34 | 0.53 | 0 | 0 | 0 | 0 |
| Prev(%) | 58.94 | 57.62 | 65.73 | 60.96 | 68.46 | 72.31 | 64.29 | 72.67 | 50.32 | 23.67 | 17.24 | 17.85 | 21.26 | 22.12 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.43 | 0.31 | 10.38 | 1.41 | 0.70 | 1.13 | 0.73 | 0.88 | 0.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.04 | 0.89 | 32.85 | 2.94 | 2.02 | 3.29 | 1.86 | 2.28 | 0.92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.24 | 0.77 | 14.78 | 4.42 | 1.45 | 1.83 | 2.06 | 2.22 | 0.81 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 58.27 | 59.76 | 70.12 | 67.74 | 64.96 | 77.08 | 65.42 | 71.29 | 53.28 | 0 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.04 | 0.01 | 0.77 | 0.05 | 0.11 | 0.11 | 0.28 | 0.48 | 0.05 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.01 | 0.02 | 2.23 | 0.13 | 0.34 | 0.29 | 0.77 | 0.89 | 0.14 | 0 |
| Stdev | 0.19 | 0.02 | 1.84 | 0.10 | 0.19 | 0.26 | 0.60 | 1.27 | 0.11 | 0 |
| Prev(%) | 33.78 | 35.29 | 76.74 | 82.86 | 89.29 | 66.00 | 78.79 | 87.10 | 67.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
